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Abstract: Ischemic-reperfusion (I/R) injury induced a remodeling of protein and lipid homeostasis,
under oxidative stress and inflammatory status. Starvation occurring during I/R is a condition leading
to autophagy activation, which allows abnormal material clearance or amino acid, or both, and fatty
acid (FA) recycling essential for survival. This study investigated the lipid reshaping, peroxidation,
and related-signaling pathways, in rat brain endothelial cells (RBE4) subjected to 3 h of oxygen and
glucose deprivation (OGD) and restoration of standard condition (I/R in vitro model). Lipids and
proteins were analyzed after 1 or 24 h of oxygen and nutrient restoration. Together with the oxidative
stress and inflammatory status, I/R injury induced a reshaping of neutral lipids and biogenesis of lipid
droplets (LD) with excessive lipid storage. The increase of LC3-II/LC3-I ratio, an autophagy marker,
and LC3 co-localization with LD suggest the activation of lipophagy machinery to counteract the cell
engulfment. Lipophagy leads to cholesterol ester (CE) hydrolysis, increasing free cholesterol (FC)
secretion, which occurred by specific transporters or unconventional exocytosis pathways, or both.
Here, we propose that an unconventional spreading of FC and other lipid metabolites may influence
the neurovascular unit (NVU) cells, contributing to Blood brain barrier (BBB) alteration or adaptation,
or both, to the cumulative effects of several transient ischemia.
Keywords: oxygen and glucose deprivation; lipophagy; lipid droplets; cholesterol; ischemia;
vessel disease
1. Introduction
The blood brain barrier (BBB) represents an important structure to regulate the exchanges between
the peripheral circulation and the brain parenchyma [1]. According to BBB functional importance in
controlling molecular traffic, the plasmalemma of brain endothelial cells is characterized by a specific
membrane structure based on the unique combination of transport (eﬄux and influx transporters),
metabolic (metabolic enzymes) and physical (lipid membrane with tight junctions) barrier properties [2].
Indeed, specific close-fitting membrane phospholipid (PL) and cholesterol domains [3] allow the
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flux of small gaseous molecules (oxygen, CO2) but not of certain hydrophobic molecules [4]. Thus,
alterations in these properties lead to loss of BBB integrity and the consequent disruption of the
neurovascular unit (NVU), a complex and well-organized cellular network (neurons, astrocytes,
pericytes, brain endothelial cells, and extracellular matrix component) that physiologically preserves
and sustains brain homeostasis [5].
The blood brain barrier (BBB) represents an important structure to regulate the exchanges between
the peripheral circulation and the brain parenchyma [1]. According to BBB functional importance in
controlling molecular traffic, the plasmalemma of brain endothelial cells is characterized by a specific
membrane structure based on the unique combination of transport (eﬄux and influx transporters),
metabolic (metabolic enzymes) and physical (lipid membrane with tight junctions) barrier properties [2].
Indeed, specific close-fitting membrane phospholipid (PL) and cholesterol domains [3] allow the
flux of small gaseous molecules (oxygen, CO2) but not of certain hydrophobic molecules [4]. Thus,
alterations in these properties lead to loss of BBB integrity and the consequent disruption of the
neurovascular unit (NVU), a complex and well-organized cellular network (neurons, astrocytes,
pericytes, brain endothelial cells, and extracellular matrix component) that physiologically preserves
and sustains brain homeostasis [5].
In the last decade, several studies demonstrated that, ischemia-reperfusion (I/R) injury is one of the
main causes in BBB break-down with the consequent enhancement in cerebral oxidative stress damage
and neuroinflammatory response [6,7]. Alterations in lipid metabolism are strongly implicated in these
events. Hypoxia, indeed, induces metabolic changes that influence fatty acid (FA) amounts and neutral
lipid storage [8]. An overloading of lipid droplets (LD) might be potentially harmful since the gathering
of neutral triglycerides (TGs) is accompanied by the accumulation of lipid species derived by the
metabolism of the long chain FA and that are involved in lipoapoptosis [9,10]. Moreover, under oxidative
stress, the increment of poly-unsaturated FAs (PUFAs) leads to their peroxidation, with the release
of oxidative products, such as malondialdehyde (MDA) [11,12]. Kirac [13] and colleagues have
recently shown that hepatic I/R injury induced lipid-mediated inflammatory endogenous pathways,
altering levels of arachidonic acid (AA) and other omega-6 and omega-3 PUFAs.
Furthermore, our recent evidences demonstrated that, in brain endothelial cells subjected to
oxygen and glucose deprivation and restoration (OGD/ogR), an in vitro modeling of I/R, the membrane
cholesterol amount increased, while no changes in PLs and gangliosides (GG) were detected.
The observed increase of cholesterol outcomes in the amyloidogenic metabolism and the amyloid-β
(Aβ) production/accumulation during OGD/ogR [14].
All these events represent the additive stress generated in post-ischemic injury and are strictly
implicated in the progressive decline of cognitive functions. The present study is a step forward in
the evaluation of lipid alterations under OGD/ogR treatment, by monitoring fluctuations in FA and
neutral lipid levels, as well as pathways linked to them.
2. Results and Discussion
2.1. OGD/ogR Rearranges Rat Brain Endothelial Cells (RBE4) Total FA Profile
Alteration in level and metabolism of lipids, as well as their localization in cellular membranes,
is strictly related to cell dysfunctions. Under ischemia-reperfusion, lipid changes are targets and players
of oxidative stress and inflammation that mediate death or survivor messages. For these reasons
lipid fluctuations may represent an important mechanism involved in endothelial cell reaction to
ischemic injury. Therefore, we evaluated the possible modification in endothelial cell lipid composition
induced by OGD/ogR; firstly, we analyzed the total FA composition in RBE4 after 1 and 24 h of ogR.
The complete FA cell profile is reported in Table S1; after treatment, it is possible to observe a significant
increase of all PUFAs, in particular at ogR1h compared to control.
The relevant results are depicted in Figure 1; considering whole cell FA profile, the major FAs
modified were the n-6 AA (AA C20:4) and n-3 PUFAs, such as eicosapentaenoic acid (EPA, C20:5) and
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docosahexaenoic acid (DHA, C22:6) (Figure 1A), that significantly increase at ogR1h, remaining higher
than control at ogR24h.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 3 of 17 
 
 
Figure 1. Total polyunsaturated fatty acid (PUFA) content of rat brain endothelial cells (RBE4) cells 
and of purified phosphatidylcholine (PC) after oxygen and glucose deprivation and restoration 
(OGD/OgR) treatment for 1 and 24 h. Cells, after OGD/ogR treatment, were collected and lipids were 
extracted by different mixture of methanol/chloroform. Cell FAs (fatty acids) were measured as FA 
methyl esters (FAME) by a GC (Agilent Technologies 6850 series II, Santa Clara, CA, US) equipped 
with flame ionization detector. FAME were quantified using the chromatographic peak area 
according to the internal standard (IS) method. Histograms represent the most relevant results of 
whole cell (A), and PC (B) FA composition. The data are normalized to cellular protein content and 
expressed as mean ± S.E. from three independent experiments, * p < 0.05, ** p < 0.01 vs. control. 
After HPLC purification of neutral lipids, their FA percentage distribution showed no 
substantial change of total PUFA at ogR1h followed by a significant decrease during the successive 
24 h (Table 1). Nevertheless, analyzing the two classes of PUFAs, we observed a different trend: n-6 
PUFA, in particular AA, significantly decreased during ogR (24 h), while n-3 PUFA were significantly 
enriched at ogR1h, returning to control levels at ogR24h (Table 1). 
On the other hand, the analyses of the different PL classes showed no changes in FA composition 
except for the phosphatidylcholine (PC) that was significantly enriched in AA and in EPA (Figure 
1B). It is worth of note that the increase in AA in PC corresponds to a decrease in neutral lipids, 
suggesting a remodeling of this specific FA through the lipid species. The increment in membrane 
resident-PUFAs, AA in particular, during reoxygenation may represent a damaging event for cells, 
since they are the main substrates for lipid peroxidation under oxidative conditions. In parallel, n-3 
PUFA enrichment in neutral lipids (TG and CE) at ogR1h might be a mechanism for FA storage in 
LD to support the cell lipid homeostasis [15,16]. In order to deeply understand these pathways, we 
Figure 1. Total polyunsaturated fatty acid (PUFA) content of rat brain endothelial cells (RBE4) cells and
of purified phosphatidylcholine (PC) after oxygen and glucose deprivation and restoration (OGD/OgR)
treatment for 1 and 24 h. Cells, after OGD/ogR treatment, were collected and lipids were extracted
by different mixture of methanol/chloroform. Cell FAs (fatty acids) were measured as FA methyl
esters (FAME) by a GC (Agilent Technologies 6850 series II, Santa Clara, CA, US) equipped with flame
ionization detector. FAME were quantified using the chromatographic peak area according to the
internal standard (IS) method. Histograms represent the most relevant results of whole cell (A), and PC
(B) FA composition. The data are normalized to cellular protein content and expressed as mean ± S.E.
from three independent experiments, * p < 0.05, ** p < 0.01 vs. control.
To understand if FA composition changes were reflected in the FA profile of a specific lipid class,
we purified and analyzed also the neutral and PL FA profiles.
After HPLC purification of neutral lipids, their FA percentage distribution showed no substantial
change of total PUFA at ogR1h followed by a significant decrease during the successive 24 h (Table 1).
Nevertheless, analyzing the two classes of PUFAs, we observed a different trend: n-6 PUFA, in particular
AA, significantly decreased during ogR (24 h), while n-3 PUFA were significantly enriched at ogR1h,
returning to control levels at ogR24h (Table 1).
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Table 1. FA composition of neutral lipids purified by High Performance Liquid Chromatography
(HPLC) from RBE4 endothelial cells after OGD/ogR treatment for 1 and 24 h.
%
CTRL ogR1h ogR24h
Mean ± S.E. Mean ± S.E. Mean ± S.E.
C16:0 19.308 1.025 18.683 0.634 18.820 0.098
C16:1 6.219 0.474 6.288 0.600 5.579 0.720
C18:0 11.560 1.490 9.620 0.432 10.354 1.141
C18:1 40.927 2,685 43.309 0.981 48.557 1.557
C18:2 9.002 1.297 7.996 0.448 5.982 0.379
C18:3 n-3 0.942 0.181 1.102 0.252 1.265 0.118
C20:3 1.173 0.406 0.674 0.385 0.593 0.315
C20:4 n-6 4.294 0.066 3.962 0.127 3.217 0.107
C20:5 4,425 0.621 5.386 0.319 3.794 0.756
C22:5 1.147 0.040 1.774 0.356 0.625 0.083
C22:6 1.002 0.140 1.206 0.069 1.214 0.267
PUFA 21.985 1.414 22.099 1.143 16.690 0.848
n-6 PUFA 14.469 1.425 12.631 0.854 9.791 0.647
n-3 PUFA 6.979 0.342 9.467 0.387 6.899 0.965
Total FA (µg/mg prot) 20.634 2.497 16.929 0.998 23.904 0.699
Data are reported as mean ± S.E. from three independent experiments, bold numbers indicate a significant statistical
difference vs. control (p < 0.05).
On the other hand, the analyses of the different PL classes showed no changes in FA composition
except for the phosphatidylcholine (PC) that was significantly enriched in AA and in EPA (Figure 1B).
It is worth of note that the increase in AA in PC corresponds to a decrease in neutral lipids, suggesting
a remodeling of this specific FA through the lipid species. The increment in membrane resident-PUFAs,
AA in particular, during reoxygenation may represent a damaging event for cells, since they are the
main substrates for lipid peroxidation under oxidative conditions. In parallel, n-3 PUFA enrichment in
neutral lipids (TG and CE) at ogR1h might be a mechanism for FA storage in LD to support the cell lipid
homeostasis [15,16]. In order to deeply understand these pathways, we evaluated lipid peroxidation
products and AA cascade on one side, as well as TG amount and LD formation on the other side.
2.2. Lipid Peroxidation and AA Cascade Activation Under OGD/ogR
Accordingly to previously literature [13,17], we evaluated the proteins involved in AA
metabolism. In particular, we analyzed protein levels of cPLA2, the key enzyme in AA release
from PC [18], and of inducible COX-2 that catalyzes the conversion of AA in inflammatory mediators
(prostaglandins, thromboxane, leukotrienes). Recent findings have already highlighted the activation
of the cPLA2/AA/COX-2 pathway following cerebral [17] or hepatic ischemic injury [13] as an
inflammatory response.
Therefore, RBE4 cells, subjected to OGD treatment for 3 h, were successively harvested at 1 and
24 h of ogR to evaluate cPLA2 in membrane-enriched fractions (MEF), while COX-2 was evaluated in
the whole cell homogenate.
As shown in Figure 2A, cPLA2 protein level increased at ogR1h of about 60%, remaining higher
than the control at ogR24h. In the same way, we observed a significant 90% increase of COX-2 protein
at ogR1h that enhanced up to 270% at ogR24h (Figure 2B).
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Figure 2. Analysis of proteins involved in arachidonic acid (AA) metabolism in ogR. Cells subjected 
to OGD treatment were harvested in hypotonic solution at 1 h and 24 h ogR. Total homogenate aliquot 
was collected and membrane-enriched fractions (MEFs) were obtained by ultracentrifugation. Equal 
amounts of MEF or homogenate samples (as protein) were subjected to SDS-PAGE and WB analysis. 
Ponceau staining of total lanes was employed to perform band quantification of MEF samples, while 
total lysates were normalized by β-actin content. Panel A represents the % of cPLA2 increment and 
panel B the % of COX-2 protein levels with respect to CTRL. The data are expressed as mean ± S.E. 
from three independent experiments, * p < 0.05, ** p < 0.01 vs. control. 
COX-2 and cPLA2 increased together with the AA increment trend in PL and in the whole cell 
are in line with the literature evidences on cPLA2/AA/COX-2 pathway activation during the 24 h 
following reperfusion in an in vivo model of transient focal cerebral ischemia (tFCI) [17]. 
Figure 2. Analysis of proteins involved in arachidonic acid (AA) metabolism in ogR. Cells subjected
to OGD treatment were harvested in hypotonic solution at 1 h and 24 h ogR. Total homogenate
aliquot was collected and membrane-enriched fractions (MEFs) were obtained by ultracentrifugation.
Equal amounts of MEF or homogenate samples (as protein) were subjected to SDS-PAGE and WB
analysis. Ponceau staining of total lanes was employed to perform band quantification of MEF samples,
while total lysates were normalized by β-actin content. Panel (A) represents the % of cPLA2 increment
and panel (B) the % of COX-2 protein levels with respect to CTRL. The data are expressed as mean ±
S.E. from three independent experiments, * p < 0.05, ** p < 0.01 vs. control.
COX-2 and cPLA2 increased together with the AA increment trend in PL and in the whole cell are
in line with the literature evidences on cPLA2/AA/COX-2 pathway activation during the 24 h following
reperfusion in an in vivo model of transient focal cerebral ischemia (tFCI) [17]. Interestingly, our data
suggest that the pathway of AA refurbishment in PL might be mediated by a decrease of AA storage in
neutral lipids and that this lipid reshaping could be at the base of the inflammatory response.
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In parallel, MDA was evaluated as PUFA peroxidation product. MDA content increased in a
time dependent-manner along ogR in endothelial cells, suggesting a persistent condition of oxidative
stress (Figure 3).
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Figure 3. Evaluation of lipid peroxidation in RBE4 after OGD/ogR. Lipid peroxidation was evaluated
by measuring malondialdehyde (MDA) content in control and OGD/ogR RBE4 cells as marker of lipid
peroxidation by HPLC- Evaporative light scattering detector (ELSD) system. The data are normalized
to cellular protein content (nmol/mg protein) and expressed as mean ± S.E from three independent
experiments, ** p < 0.01 vs. control, § p < 0.05 vs. ogR1h.
2.3. OGD/ogR Induces TG Increase and LD Formation
Hypoxia has been shown to stimulate lipid storage and inhibit lipid catabolism in cultured
cardiac myocytes and macr phages [8], although the effects of re-oxygenation are not well understoo
from this p int of view. Interestingly, under our experimental conditions, we observed a significant
tim dependent increme t in TG co t nt along to ogR (Figure 4). TG increase might be du to the
activation of hypoxia-inducible factor 1α (HIF-1α), which seems to regulat lipin-1 [15], protein that
catalyzes the penultimate step of TG synthesis [19]. Accordingly, under our experimental conditions,
we observed the increase of HIF-1α [20].
M reover, suppr ssion of FA oxidation and increased lipid storage capacity was associated with
hypoxia inducible factors activati n [15,21]. Therefore, we hypothesize th t ne ly synthetized TG
might be quickly stored in LD.
To investigate this hypothesis, LD were marked with BODIPY 493/503 specific for neutral lipids.
The results are shown in Figure 5, where it is possible to observe LD increase after 1 and 24 h ogR.
In particular, cells were stained also with DAPI and phalloidin to mark cell shape and cytoskeleton.
Notably, lipid bodies appear localized in perinuclear area in polarized shape at ogR1h (Figure 5B),
while, after 24 h ogR, they seemed to move towards plasma membrane following the specific direction
of actin filaments (Figure 5C).
These data suggest that de-novo generated LD might be committed to exocytosis after 24 h from
restoration. Indeed, inflammatory conditions increase BBB transcytosis process that is responsible
of different macromolecule uptake or release, or both, to neuronal cells [22]. n-3 PUFAs, which are
not synthetized by neurons, must be delivered to brain parenchyma where they can exert their
neuroprotective effects against ischemic insult [23,24].
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Figure 5. Lipid droplet (LD) staining in RBE4 after OGD/ogR. RBE4 cells were fixed
in 4% paraformaldehyde and permeabilized at 4 ◦C with 0.5% Triton X-100 Hepes Buffer
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid. Images show LDs stained with BODIPY 493/503,
actin filaments stained with phalloidin and nuclei stained with DAPI (blue fluorescence) in control (A),
ogR1h (B), and ogR24h (C) RBE4 cells. Fluorescence images were collected under a Nikon Eclypse
microscope with immersion objective at 60×magnification.
2.4. OGD/ogR-Induced Lipophagy
Oxygen and nutrient starvation leads to LD biogenesis with the specific aim to maintain the redox
homeostasis and managing the lipid unbalance when microenvironment rapidly changes, as in the
case of ogR [25]. Interestingly, both autophagy and cPLA2 protein seem to play a role in LD generation,
mobilizing the available endogenous and structural lipids, in a fine equilibrium between FA-induced
lipotoxicity and FA employment for cell survival [26,27].
Autophagy is catabolic process that is activated under diverse str ssful conditions,
including OGD [28], to pr vent accumulation of damaged cellular components (proteins, lipids
mitochondria, etc.). In eed, nutrient deprivation, hypoxia, elevated ROS levels, lipid overload, and
increased unsaturated FAs are all events that occur in OGD nd that lead to autophagy induction [25].
Moreover, autop agy flux is affected also by the presence of intracellular MDA, triggering an atypical
autophagy pathway independent from Beclin-1 [29], a protein involved in the regulation of initiation
process of macroautophagy. Macroautophagy is characterized by the biogenesis of autophagy vacuoles
(AV), marked by the PE-conjugated form of microtubule-associated proteins 1A/1B light chain 3B
Int. J. Mol. Sci. 2019, 20, 3752 8 of 17
(LC3-II). Low levels of MDA, indeed, increased LC3-II/LC3-I ratio (lapidated/de-lipidated form) and
decreased p62 levels (an autophagy-selective substrate), while high levels seems to inhibit the flux [29].
Thus, considering the observed LD biogenesis and the increase of MDA along the ogR, we evaluated
Beclin-1, LC3II/I ratio and p62. As observed by Ye and colleagues [29], Beclin-1 levels did not change
after OGD/ogR, while LC3II/I ratio significantly increased at ogR1h (+80%), decreasing in the following
24 h (+32% vs. CTRL). A time-dependent p62 decrease was observed during the ogR, statistically
significant at 24 h (Figure 6). Data, hence, suggest the activation of such autophagy machinery with
AV biogenesis occurrence.
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Figure 6. Autophagy marker analysis in RBE4 after OGD/ogR. Cells subjected to OGD/ogR treatment
were harvested in lysis buffer, then equal amounts of homogenate samples (as protein) we analyzed
by WB. LC3II/I, p62 and Becli -1 were detected with specific antibodies and r vealed by enhanced
chemiluminescence (ECL). Sample were normalized onβ-actin immunore ctivity. Histograms repr sent
the % of prot in levels respect to control as mean ± S.E. from three indepe dent experiments, * p < 0.05,
*** p < 0.001 vs. cont l; § p < 0.05 vs. ogR1h.
Under starvation conditions, LC3-II seems to co-localize with LD [30,31], indicating a fusion
between LD and AV with the generation of lipo-aut phagosomes, and so the occurrence of lipophagy
(Figure 7). This autop agy pattern is activated in order to deliver lipids to lysosomes r to exocytosis.
Accordingly, immunofluorescence analysis demonstrated a co-localization between LD (green) and
LC3 (red) at ogR1h (Figure 7K) that seems to reduce at ogR24h, lthough a high signal was detected
(Figure 7L).
Altogether, our data suggested that the autophagy machinery might regulate both AV and LD
biogenesis as a coordinated mechanism for the maintenance of lipid cellular homeostasis.
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2.5. OGD/ogR-Induced CE Hydrolysis and FC Release in Extracellular Milieu
We tried to disclose wheth r LD during gR were committed to lysosomal degrad tion or
exocyto i , or both, taking in consideration possible changes in cholesterol ester (CE) level , another lipid
which is accumulated in lipid cellular bodies together with TG as a source of FAs. Remarkably,
we observed in treated cells that CE fraction at ogR1h significantly decreased about 40%, from 13.04
to 8.12 µg/mg proteins, while at ogR24h, CE content returned to the control condition (Figure 8A);
this data might indicate a possible CE hydrolysis by lysosomal mechanism.
CE decrease might play a role in the previously described free cholesterol (FC) enrichment at
ogR1h in cellular membranes [14], probably influencing the FC availability. Notably, the increase of CE
hydrolysis was discovered along with Aβ stabilization and enhancement [32], which we also observed
in our ischemic model [20].
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Figure 8. Changes in intracellular and extracellular cholesterol content under OGD/ogR. Cells,
after OGD/ogR treatment, were collected and lipids were extracted by different mixture of
methanol/chloroform. Free cholesterol (FC) and cholesterol ester (CE) were evaluated by HPLC-ELSD.
Panel A represents intracellular CE concentration normalized to protein content. Panel (B) depicts with
circle charts the molar percentage distribution of intracellular CE and FC. Panel (C) reports the cell
medium FC content normalized for protein of cells seeded in each analyzed plate. Data are reported as
mean ± S.E. (A,C) from three independent xperiments, * p < 0.05, ** p < 0.01 vs. control; § p < 0.05
vs. ogR1h.
Thus, we got an overall picture f cholesterol distribution in cells during the treatment, and we
observed a consistent alteratio compared to the control (26% E and 74% FC, molar percent ge)
at ogR1h (17% CE and 83% FC), as shown in Figure 8B. FC av ilability under OGD/ogR could be
a damaging ve t that needs to be counteracted with its eﬄux from BBB endothelial cells. Indeed,
hydrolysis of LD-associated CE is recognized as a fundamental step for cholesterol eﬄux [33] that is
associated to autophagy machinery activation in lipid-loaded cells [34,35]. Therefore, we investigated
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the amount of FC released in the extracellular medium, finding an increase of about 75% at ogR1h,
from 3,75 µg/mg proteins to 6,62 µg/mg proteins. Then, extracellular FC amount did not significantly
change during the following 24 h of recovery with respect to the first h (Figure 8C). The way in which
FC is released outside cells need to be elucidated. Here, we propose that the FC eﬄux occurred
by specific active transporters, such as ATP binding cassette (ABC) transporters, for lipophilic and
amphipathic molecules, including lipids and xenobiotics. Since data from the literature indicate that
ischemia might influence the expression of different ABC pumps [36], we analyzed the protein levels of
drug transporter ABCB1/MDR1. Data showed a time-dependent increase in MDR1 during ogR, with a
significant increment at ogR24h, suggesting a possible ABC transporter involvement in extracellular
FC release (Figure 9).
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were harvested in lysis buffer, then eq al amou ts of ho ogenate samples (as protein) were subj cted
to SDS-PAGE an WB analysis. MDR1 was detected with the specific antibody and revealed by ECL.
Sampl were normalized on β-actin immun reactivity. Histograms represent the % of protein l vels
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Interestingly, the increased protein level of cholesterol transporters has been also associated to
release of xtracellular vesicle (EVs) [37]. S veral evid nces described the role of EV in ensuring
cholesterol homeostasis and highlighted the presence of hole terol-ric lipid rafts regio in EVs
membran [37]. Thus, FC export mi t also occur by fusion of LD wit other organ lles releasing
EVs [38], or by direct fusion with plasma membrane through an unconventional secretory pathway
driven by the chaperone p62 carrier [9]. Indeed, as shown in Figure 6, p62 protein levels decrease at
ogR24h when LD seems to be addressed to secretion, indicating that several mechanisms might be
involved in cholesterol homeostasis during reperfusion.
3. Materials and Methods
3.1. Materials
All commercial chemicals were of the highest available grade. Solvent solutions were from
Carlo Erba (Milano, Italy). All powdered reactants, solutions for electrophoresis, Phalloidin
Tetramethylrhodamine B isothiocyanate, DAPI, and anti-β-actin antibody, were from Sigma Chemical
Co (St. Louis, MO, USA). Lipid standards, FA s, neutral lipids, PL, and Avanti Polar Lipids were
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from Sigma Chemical Co. (St. Louis, MO, USA). The 5% CO2:95% N2 gas cylinder came from
Sapio (Monza, Italy). Collagen I rat tail solution for RBE4 cell culture, BODIPY 493/503, and Alexa
Fluor® 567-labeled goat anti-rabbit IgG were from Invitrogen, Life Technologies Italia Fil. (Monza,
MB, Italy). Stock solutions for RBE4 cell culture included: alpha-MEM medium with glutamax-1
and Ham’s F-10 nutrient medium, geneticin solution antibiotic, and Euroclone (Milano, MI, Italy).
The complete protease inhibitor cocktail came from Roche Diagnostics S.p.A (Milano, Italy). Anti-cPLA2
antibody came from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Anti-Cox-2, anti-LC3-I/II
anti-p62, and anti-Beclin-1 antibodies were from Cell Signaling Technology (Danvers, MA, USA).
Secondary horseradish peroxidase (HRP) -conjugated antibodies and enhanced chemiluminescence
(ECL) SuperSignal detection kit were from Pierce (Rockford, IL, USA).
3.2. Cell Cultures
The rat brain endothelial (RBE4) clone showed typical endothelial morphology and retains many
brain endothelial cell characteristics [39–43]. RBE4 cells, provided as a gift by M. Aschner (Department
of Pediatrics, Vanderbilt Kennedy Centre, Nashville, TN, USA), were plated on collagen (50 µg/mL
in acetic acid 0.02 M)-coated dishes or flasks and were grown in the presence of 44% alpha-MEM:
44% F-10 Nutrient supplemented with 10% heat inactivated fetal bovine serum (FBS). RBE4 cells were
plated in collagen-coated dishes (12,500 cells/cm2) and maintained at 37 ◦C in a 5% CO2 atmosphere
for three days (80% confluence) before treatment.
3.3. OGD Treatment
RBE4 cells were subjected to OGD for 3 h, as previously described [14,20]. Afterward, OGD,
normoxic and normoglycemic conditions were restored for 1 h and 24 h. Cells were replaced in normal
culture conditions (37 ◦C in a 5% CO2 atmosphere), and BSS in each dish was supplemented with
restoration solution containing 5mM glucose and 10% FBS in culture medium. From here on, we will
use the term “oxygen and glucose Restoration” (ogR) to indicate “normoxic and normoglycemic
conditions restoration post-OGD”. RBE4 untreated cells were maintained in normal culture conditions
and collected together with treated cells subjected to ogR for 24 h.
3.4. Homogenate Obtainment and MEFs Isolation
At 1 and 24 h of ogR, cells were scraped in PBS containing the protease inhibitor cocktail. Pellets
were homogenized with hypotonic solution (Tris-HCl pH 7.4 1 mM, EDTA pH 7.4 1 mM, KCl 15 mM,
NaCl 30 mM, protease inhibitor cocktail), then an equal volume of isotonic solution 2X (sucrose 0.5M,
Tris-HCl pH 7.4 2 mM, EDTA pH 7.4 2 mM, protease inhibitor cocktail) was added. To isolate MEFs,
samples were centrifuged 12 min at 800× g in order to separate nuclei-enriched pellet and post nuclear
supernatant (PNS). PNS was ultracentrifuged 1 h at 100,000× g, and the resultant membrane-enriched
pellet was resuspended in an MBST buffer (MES pH 6.5 25 mM, NaCl 150 mM, Triton X-100 1%,
PMSF 1 mM, protease inhibitor cocktail). cPLA2 protein levels were analyzed in MEFs.
3.5. Electrophoresis and Immunoblotting
Protein analysis was performed by SDS-PAGE electrophoresis on 12% polyacrylamide tris-glycine,
protein transfer to a nitrocellulose membrane (Amersham, GE Healthcare Europe GmbH, Milano,
Italy), revelation by Ponceau staining (Sigma Chemical Co., Milano, Italy), and immunoblotting
with specific antibodies. Electrophoresis separation and western blotting were carried out on equal
amounts (as protein) of homogenate or MEF samples, in order to investigate protein level expression
in cellular membranes. Nitrocellulose membranes were blocked in TBS-Tween 0.1% or 0.2% buffer
containing 5% non-fat milk or 3–5% BSA and probed with specific antibodies diluted in the same
solution. Immunoblottings were performed using anti-cPLA2 (1:200), anti-COX2 (1:1000), anti-LC3 I-II
(1:1000), anti-p62 (1:1000), anti Beclin-1 (1:1000), and anti-β-actin (1:1500) antibodies. Immunoreactive
proteins were revealed by ECL and semi-quantitatively estimated by LAS4000 Image Station (GE
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Healthcare Italia, Milano, MI, Italy). Normalization in the same sample was carried out with respect to
β-actin homogenate samples [44,45] and to the total amount of proteins detected by Ponceau staining
in MEFs, permitting a straightforward correction for lane-to-lane variation [46,47].
3.6. Lipid Extraction and Quantification
Cell and cell medium lipids were extracted according to Folch, with minor modifications,
as previously described [48]. Briefly, cell pellets were homogenized with chloroform/methanol
1:2, centrifuged to recover the lipid extract and extracted again two times. Cell medium was
lyophilized before extraction. Each solvent used for extraction and analysis contained 0.045 mM
3,5-di-tert-4-butylhydroxytoluene (BHT) to avoid PUFA oxidation.
Purification of single PL moieties was achieved with an High Performance Liquid
Chromatography-Evaporative light scattering detector (HPLC-ELSD) system equipped with a silica
normal-phase LiChrospher Si 60 column (length 250 mm, I.D 4.6 mm, and film thickness 5 µm, Merck,
Darmstadt, Germany). The chromatographic separation was achieved as previously described [49].
For PL quantitation, a mixture of standard PL was injected prior to samples in three different
concentrations to construct a calibration curve for each single PL species [50].
Neutral lipids from cellular and medium lipid extract were separated and accurately quantified
by high performance liquid chromatography on a LiChrospher SI 60 5 mm, 250 × 4 HPLC column,
and using ELSD detector according to [51]. The mobile phase consisted of solvent A: isooctane,
tetrahydrofuran 99:1 voL/voL and solvent B: acetone, dichloromethane 2:1 voL/voL. The flow rate
was 1.6 mL/min. ELSD detector was settled as follows: pressure 3.5 bar, temperature 50 ◦C, gain 8.
The injection volume was 20µL. Four different concentrations of free and esterified cholesterol and TGs
standards were injected prior to sample to construct a calibration curve.
The total FA composition of samples and purified phospho- and neutral-lipids was determined
by gas chromatography (Agilent Technologies 6850 series II, Santa Clara, CA, USA) as previously
described [52]. Lipids were derivatized (sodium methoxide in methanol 3.33% (w/v)) to obtain FA
methyl esters (FAME). Prior to derivatization, a known amount of internal standard (IS) (C17:0 TG) was
added to each sample to correct for yield and recovery of the reaction. A standard mixture containing
all FAME was injected as calibration for quantitative analysis.
3.7. MDA Analysis
Lipid peroxidation was assessed measuring MDA, according to Karatas and colleagues [53], with
slight modifications. Malondialdehyde was determined by HPLC (Jasco, Japan) equipped with a UV
detector. A C18 column was used at ambient temperature. MDA standards were prepared from TEP
(1,1,3,3-tetraethoxypropane) as previously described [49]. For sample preparation, cell lysates were
treated with 0.1 M HClO4 to allow protein precipitation and release of bound MDA. Samples were
centrifuged at 4500g for 5 min and supernatants were used for HPLC analysis. The mobile phase was
30 mM KH2PO4/methanol/acetonitrile (72/18/11, v/v); the flow rate was 1 mL/min. Chromatograms
were monitored at 254 nm.
3.8. LD and LC3 Immunostaining
At 1 and 24 h of OgR, RBE4 cells, grown on glass coverslips, were fixed in 4% paraformaldehyde at
room temperature for 20 min and permeabilized at room temperature for 6 min with 0.5% triton X-100
in Hepes Buffer (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 20 mM. To stain actin filaments,
cells were incubated with phalloidin-TRITC dilute 1:40 in PBS, at room temperature, for 40 min. To stain
AVs, cells were incubated with LC3A/B (D3U4C) XP® Rabbit antibody, 1:100, at room temperature,
for 120 min and, subsequently, incubated with secondary antibody Alexa Fluor® 567-labeled goat
anti-rabbit IgG, 1:1000, at room temperature, for 30 min, then cells were washed five times with PBS
and incubated with BODIPY 493/503 1:100, at room temperature, for 15 min. Nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI)1:1000, at room temperature for 5 min. Fluorescence images
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were collected under a Nikon Eclypse TE200 inverted microscope with immersion objective at 60×
magnification and photographed with Nikon digital camera (Nikon, Japan).
3.9. Statistical Analysis
All data are expressed as mean ± S.E. of three separate experiments performed in triplicate.
The differences were calculated by means Student’s t test. A p value < 0.05 was considered to be
statistically significant with respect to the control and is indicated by an asterisk, p value < 0.01 is
indicated by two asterisks, and p value < 0.001 is indicated by three asterisks. § indicates a p value < 0.05
with respect to ogR1h.
4. Conclusions
In this study we revealed a reshaping in the lipid profile of RBE4 cells in response to stress conditions
induced by ischemic injury. In particular, we found AA enrichment in PC, probably refurbished
from neutral lipids, in parallel to the increment of lipid peroxidation products and the activation
of the cPLA2/AA/COX-2 cascade. Accordingly, lipophagy activation at ogR1h occurs to effectively
remove lipid excess modulating lipid homeostasis and intra- extra- cellular signaling. LD could be
driven, at least in part, to unconventional exocytosis, as suggested by immunofluorescence data of
ogR24h, probably to counteract the intracellular TG overload [9]. In addition, the secretion of n-3 PUFA
contained in LD might positively influence neighboring cells of NVU, promoting an anti-inflammatory
phenotype of microglia [54]. Indeed, PUFA exchange from endothelial cells to neurons has been
associated to neurotransmission and neuroprotection [55]. On the other hand, exocytosis of lipid
metabolites (i.e., ceramides, diacylglycerols, and PUFA derived lipid mediators, obtained by TG in LD)
might induce pro-apoptotic signals in the adjacent cells [10].
Moreover, lipophagy induced to prevent intracellular cholesterol accumulation could become
a doubled-edged sword since, according to our previous evidences [14], FC released by hydrolysis
of CE affects the cell membrane composition leading to Aβ production. Furthermore, cholesterol
seems to play a role in the regulation of EVs release, enhancing the cholesterol-rich microparticle (MP)
shedding [37]. In fact, elevated levels of circulating MP in plasma have been associated to several
vascular disease, including acute ischemic stroke [56]. How cell to cell communication, occurring
in response to I/R injury, may negatively or positively influence the NVU is a key point of analysis,
in particular in those pathological conditions of repeated ischemia manifesting the cumulative effects
of several transient ischemic injuries.
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